Roberto Bellelli
Impact in
- Aging top 10%
- Cancer Research top 10%
- MicroRNA in disease regulation
Papers in
-
- DNA Repair Mechanisms 15
- Genomics and Chromatin Dynamics 6
- CRISPR and Genetic Engineering 5
- Epigenetics and DNA Methylation 2
- RNA Research and Splicing 2
- Oncology 7
- PARP inhibition in cancer therapy 3
- Cancer-related Molecular Pathways 3
- Co-authors
- Simon J. Boulton (10 shared papers)Julian Stingele (2 shared papers)Massimo Santoro (8 shared papers)Francesca Carlomagno (3 shared papers)Sarah Maslen (2 shared papers)Giorgia Federico (3 shared papers)Mark Skehel (2 shared papers)M Chiariello (2 shared papers)
- Journals
- Cell Reports (6 papers)Molecular Cell (5 papers)Biochemical Society Transactions (2 papers)Oncogene (1 paper)Antioxidants and Redox Signaling (1 paper)
- Partner nations
- United KingdomItalyUnited States
In The Last Decade
Roberto Bellelli
22 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 87
- Aging 30
- Cancer Research 245
- Molecular Biology 1.1k
- Oncology 283
- Hematology 106
Countries citing papers authored by Roberto Bellelli
This map shows the geographic impact of Roberto Bellelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Bellelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Bellelli more than expected).
Fields of papers citing papers by Roberto Bellelli
This network shows the impact of papers produced by Roberto Bellelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Bellelli. The network helps show where Roberto Bellelli may publish in the future.
Co-authors
The 25 scholars most cited alongside Roberto Bellelli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 206 | |
| 2 | 2016 | 189 | |
| 3 | 2016 | 188 | |
| 4 | 2011 | 116 | |
| 5 | 2018 | 94 | |
| 6 | 2017 | 79 | |
| 7 | 2022 | 72 | |
| 8 | 2009 | 70 | |
| 9 | 2018 | 59 | |
| 10 | 2014 | 56 | |
| 11 | 2020 | 43 | |
| 12 | 2020 | 40 | |
| 13 | 2012 | 35 | |
| 14 | 2014 | 31 | |
| 15 | 2022 | 22 | |
| 16 | 2013 | 18 | |
| 17 | 2017 | 12 | |
| 18 | 2020 | 9 | |
| 19 | 2022 | 4 | |
| 20 | 2023 | 3 |
About Roberto Bellelli
Roberto Bellelli is a scholar working on Molecular Biology, Oncology, Cancer Research, Hematology and Endocrinology, Diabetes and Metabolism, having authored 23 papers that have together received 1.3k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (15 papers), Genomics and Chromatin Dynamics (6 papers), CRISPR and Genetic Engineering (5 papers), PARP inhibition in cancer therapy (3 papers), Cancer-related Molecular Pathways (3 papers), Iron Metabolism and Disorders (2 papers), Epigenetics and DNA Methylation (2 papers) and RNA Research and Splicing (2 papers). The work is most often cited by research in Aging (30 citations), Cancer Research (245 citations), Molecular Biology (1.1k citations), Oncology (283 citations) and Hematology (106 citations). Roberto Bellelli has collaborated with scholars based in United Kingdom, Italy and United States. Frequent co-authors include Simon J. Boulton, Julian Stingele, Massimo Santoro, Francesca Carlomagno, Sarah Maslen, Giorgia Federico, Mark Skehel, M Chiariello, Graeme Hewitt and Lucia De Franceschi. Their work appears in journals such as Cell Reports, Molecular Cell, Biochemical Society Transactions, Oncogene and Antioxidants and Redox Signaling.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.